Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
Healthcare | Drug Manufacturers - Major | USA
financial highlights | statements
IndexDJIA S&P500 P/E25.91 EPS (ttm)5.40 Insider Own0.07% Shs Outstand2.68B Perf Week2.48%
Market Cap375.23B Forward P/E15.30 EPS next Y9.14 Insider Trans-21.87% Shs Float2.66B Perf Month2.18%
Income14.68B PEG4.15 EPS next Q2.43 Inst Own69.40% Short Float0.46% Perf Quarter8.62%
Sales81.59B P/S4.60 EPS this Y7.60% Inst Trans-0.01% Short Ratio1.85 Perf Half Y0.29%
Book/sh22.31 P/B6.27 EPS next Y6.24% ROA1.00% Target Price145.44 Perf Year10.45%
Cash/sh7.34 P/C19.06 EPS next 5Y6.25% ROE2.50% 52W Range118.62 - 148.99 Perf YTD8.41%
Dividend3.60 P/FCF41.09 EPS past 5Y3.10% ROI17.00% 52W High-6.14% Beta0.66
Dividend %2.57% Quick Ratio1.20 Sales past 5Y2.70% Gross Margin66.90% 52W Low17.89% ATR2.01
Employees135100 Current Ratio1.50 Sales Q/Q1.00% Oper. Margin21.40% RSI (14)62.74 Volatility2.30% 1.32%
OptionableYes Debt/Eq0.51 EPS Q/Q31.00% Profit Margin1.90% Rel Volume0.61 Prev Close139.90
ShortableYes LT Debt/Eq0.46 EarningsApr 16 BMO Payout601.90% Avg Volume6.63M Price139.84
Recom2.30 SMA201.76% SMA501.97% SMA2003.00% Volume2,975,924 Change-0.04%
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
Apr-24-19 11:40AM  Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales Zacks
08:20AM  Approach Microsoft Stock Cautiously as it Goes Into Earnings InvestorPlace
07:51AM  Jim Cramer Gives His Opinion On Barrick Gold, Canopy Growth, EA, Johnson & Johnson And More Benzinga
Apr-23-19 07:14PM  Cramer's lightning round: I'm sticking with this gold stock pick CNBC Videos
07:13PM  Cramer's lightning round: I'm sticking with this gold stock pick CNBC
10:09AM  Prescription for Success? Motley Fool
Apr-22-19 01:41PM  Miguel Patricio: 10 Things to Know About the New Kraft Heinz CEO InvestorPlace
11:45AM  6 Cannabis Execs On The Strengths Of Their Businesses Benzinga
Apr-21-19 09:15AM  Johnson & Johnson posts strong revenue in 1Q Associated Press
09:15AM  Asian shares edge lower despite encouraging China GDP data Associated Press
07:57AM  Revamp at Silence does little to improve investors wellbeing Financial Times
Apr-20-19 07:45AM  You can capture a dividend above 5% and still enjoy stock-market growth MarketWatch
Apr-19-19 02:12PM  5 Top Pharmaceutical Stocks to Buy in 2019 Motley Fool
09:27AM  Health-care drama has now spread to biopharma stocks MarketWatch
Apr-18-19 11:12PM  The Top 10 Biotechnology Companies (JNJ, ROG.VX) Investopedia
03:21PM  Be Careful With Healthcare Stocks Here TheStreet.com
12:47PM  Checking in on trade war's impact on the markets Yahoo Finance Video
12:11PM  Buyer's Remorse? OTC Stock Zoom Technologies Zooms Higher Amid Potential Buyer Confusion Benzinga
10:22AM  Here Are the Key Takeaways From J&J's Q1 Earnings Report Zacks
03:16AM  Idorsia confirms 2019 spending plan as clinical trials "on track" Reuters
Apr-17-19 12:11PM  Edited Transcript of JNJ earnings conference call or presentation 16-Apr-19 12:30pm GMT Thomson Reuters StreetEvents
11:13AM  Liability Issues Weigh on Johnson & Johnson Investopedia
10:55AM  Analysts View Johnson & Johnson's Organic Growth Guidance As Conservative Benzinga
10:22AM  Stock Market News For Apr 17, 2019 Zacks
09:52AM  StockBeat - UnitedHealth Deepens Losses as Fears Over Political Risk Rise Investing.com
09:44AM  10 Best Stocks to Buy and Hold Forever InvestorPlace
09:37AM  Is More Downside Ahead for Boeing Stock? Should You Buy? InvestorPlace
07:28AM  Dow stock that's lost $34 billion in market cap in the last week could be a buy, says investor CNBC
07:18AM  5 takeaways from Johnson & Johnsons first-quarter results MarketWatch
06:28AM  Why The Rally In Johnson & Johnson Stock May Top Out At $150 InvestorPlace
06:00AM  Solid Drug Sales, Cost Control Boost Johnson & Johnson Morningstar
05:30AM  Why Scared Investors May Push Health Care Stocks Even Lower Investopedia
Apr-16-19 07:30PM  US halts sales of pelvic mesh tied to injuries in women Associated Press
06:00PM  Johnson & Johnson and United Healthcare Face a Series of Obstacles TheStreet.com
05:17PM  Qualcomm and Progressive jump while Wave Life Sciences drops Associated Press
04:57PM  What Happened in the Stock Market Today Motley Fool
04:41PM  Johnson & Johnson (JNJ) Q1 2019 Earnings Call Transcript Motley Fool
04:38PM  Wall Street edges higher on generally positive earnings Reuters
04:32PM  Johnson & Johnson Posts 1st-Quarter Earnings Beat GuruFocus.com
04:23PM  Medical Behemoth J&J Tops Quarterly Estimates, Raises 2019 Outlook Investor's Business Daily
04:23PM  Stocks End Up but UnitedHealth Weakness Slows Dow Advance TheStreet.com
04:07PM  Markets Right Now: Stocks post modest gains on Wall Street Associated Press
03:21PM  Stocks inch toward record territory as Nasdaq trades above 8,000 points MarketWatch
03:02PM  Nasdaq Today Tops 8000 As This FANG Nears Buy Point Investor's Business Daily
01:51PM  Johnson & Johnson's Legal Troubles Eat Into Earnings GuruFocus.com
01:42PM  Stocks making the biggest moves: Johnson & Johnson, Western Digital, Bank of America & more CNBC
01:03PM  Johnson & Johnson Pops Pre-Market on Earnings Investopedia
12:52PM  2 Large Health Care Companies Announce 1st-Quarter Earnings GuruFocus.com
12:17PM  Stock Market News: Johnson & Johnson Reports; AT&T Parts Ways With Hulu Motley Fool
12:04PM  The Late Morning Rundown: April 16, 2019 CNBC Videos
12:03PM  Johnson & Johnson Stock Could Break Out on Earnings Beat TheStreet.com
11:48AM  Pharmaceuticals drive J&J to better-than-expected quarterly profit Reuters
11:34AM  J&J's new ketamine-like depression drug Spravato off to 'very, very strong start,' company says CNBC
11:25AM  GLOBAL MARKETS-Stocks approach new highs on positive earnings, economic data Reuters
11:07AM  Axsome's AXS-05 Meets Goal in Phase II Study, Shares Up Zacks
10:58AM  J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View Zacks
10:51AM  Johnson & Johnson Stock Is Rising Because Earnings Showed the Good Far Outweighs the Bad Barrons.com
10:44AM  Q1 Earnings To Watch For Zacks
10:29AM  Global growth and stocks could be set for lift off, says UBS MarketWatch
10:24AM  Q1 Earnings Spigot Opens: JNJ, BAC, UNH & More Zacks
10:14AM  Stock Market Rises As These 2 Dow Jones Stocks Report Earnings Investor's Business Daily
10:04AM  Stocks trading higher following strong earnings reports CNBC Videos
09:58AM  Booming Drug Sales Rescue J&J From Gloomy Forecast Bloomberg
09:38AM  Stock Market Today Gets Lift From Dow Jones Earnings, Netflix Investor's Business Daily
09:36AM  Johnson & Johnson Rises After Topping First-Quarter Earnings Forecasts TheStreet.com
09:15AM  Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy? Zacks
09:09AM  Facebook Stock Falls, Johnson & Johnson Rises, and 3 More Tuesday Morning Movers Barrons.com
09:03AM  J&J (JNJ) Tops Q1 Earnings; Pharma Segment Drives Sales Zacks
08:57AM  US STOCKS-Wall St set to open higher on robust healthcare earnings Reuters
08:55AM  J&J profit boosted by better-than-expected pharma unit sales Reuters
08:34AM  Netflix is already over Apple and Disney as it prepares to launch this quarters earnings MarketWatch
08:05AM  Johnson & Johnson (JNJ) Q1 Earnings and Revenues Top Estimates Zacks
07:46AM  Watch an analyst break down Johnson & Johnson's Q1 earnings beat CNBC Videos
07:16AM  J&J tops estimates on strong drug sales Financial Times
07:00AM  Netflix, Bank of America, IBM, Hulu and Notre Dame - 5 Things You Must Know TheStreet.com
06:54AM  Johnson & Johnson's stock rises after profit and sales beat, raised sales guidance MarketWatch
06:51AM  Johnson & Johnson reports first-quarter sales above expectations Reuters
06:40AM  Johnson & Johnson Reports 2019 First-Quarter Results: PR Newswire
06:29AM  Johnson & Johnson beats first-quarter earnings, revenue estimates CNBC
05:45AM  Johnson & Johnson Reports Earnings Today. Heres What to Expect. Barrons.com
Apr-15-19 04:18PM  Netflix Leads The Way As Earnings Season Kicks Into Gear: Action Plan Investor's Business Daily
03:04PM  Is Johnson & Johnson Stock a Buy Ahead of Earnings? InvestorPlace
02:24PM  Johnson & Johnson earnings: Drug sales in focus amid worry about generic competition MarketWatch
01:20PM  Day Ahead: Top 3 Things to Watch Investing.com
12:54PM  Health care stocks are the worst performing sector, here are the ETFs to watch CNBC Videos
10:07AM  J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer Zacks
08:15AM  The Future Keeps Looking Better and Better for BAX Stock InvestorPlace
Apr-14-19 08:45PM  Diabetes drug may help against kidney disease, study finds MarketWatch
08:20PM  Study finds diabetes drug may prevent, slow kidney disease Associated Press
11:35AM  Bullish Start to Earnings: Cramer's 'Mad Money' Recap (Friday 4/12/19) TheStreet.com
09:21AM  3 Things to Watch in the Stock Market This Week Motley Fool
Apr-13-19 06:02PM  5 Top Dividend Kings to Buy and Hold Forever Motley Fool
Apr-12-19 11:22PM  J&J wins U.S. FDA approval for bladder cancer drug Reuters
06:32PM  J&J wins U.S. FDA approval for bladder cancer drug Reuters
06:17PM  Cramer's Game Plan: Remember this market 'has no memory' this earnings season CNBC
05:04PM  Doing Business in Lake Nona: Here's what's ahead for the growing community American City Business Journals
03:43PM  Earnings Optimism Following Bank Results Zacks
02:49PM  The shadowy system behind the high price of your drugs Yahoo Finance Video
01:39PM  U.S. FDA approves J&J's bladder cancer drug Reuters
12:35PM  3 Earnings Reports to Watch Next Week InvestorPlace
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
open in yahoo | open in reuters | open in google